A Switzerland-based biopharmaceutical company focused on therapies for rare diseases, particularly pulmonary arterial hypertension (PAH). Its portfolio has included drugs such as Tracleer, Opsumit, and Uptravi, which became widely used treatments for PAH and drove the company’s revenue growth prior ...
No congressional trades have been disclosed for Actelion Ltd (ALIOY) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.